SCHEMBL13425992

SCHEMBL13425992

Cc1cc(I)cc2c(=O)c3ccccc3[nH]c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.72
GAA P10253 4/20 0.52
HTT P42858 3/20 0.52
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
GLA P06280 2/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 1/20 0.52
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NPC1 O15118 1/20 0.51
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 1/20 0.49
TNKS2 Q9H2K2 1/20 0.49
KIF11 P52732 1/20 0.49
TDP1 Q9NUW8 2/20 0.47
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13456072 0.79 ABCB1 (0.49) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL14116119 0.78 KIF11 (0.72) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL2445797 0.78 PBRM1 (0.67) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL12086512 0.77 KIF11 (0.51) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL2444383 0.76 PIM1 (0.51) ABCB1ALDH1A1KDM4EHPGDLMNA
SCHEMBL12086493 0.74 ABCB1 (0.50) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL13425978 0.73 MAOA (0.54) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL8643080 0.72 STING1 (0.60) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL29370563 0.72 STING1 (0.60) ABCB1GAAHTTALDH1A1KDM4E
SCHEMBL13560655 0.72 GAA (0.62) ABCB1GAAHTTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS HRH3, H1-3, HRH4 ABCB1 1402/4885GAA 2640/4885HTT 1751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.